{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:43:52Z","timestamp":1792896232588,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bcp.2020.114004","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T20:30:59Z","timestamp":1588105859000},"page":"114004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-9914","authenticated-orcid":false,"given":"Tibor","family":"Stark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Di Bartolomeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Drazanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara Bianca Maria","family":"Platania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Arturo","family":"Iannotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1846-0799","authenticated-orcid":false,"given":"Jana","family":"Ruda-Kucerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"D'Addario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Kratka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Pekarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Babinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Fedotova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Giurdanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sulcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Bucolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten T.","family":"Wotjak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Zenon","family":"Starcuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Drago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Mechoulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Di Marzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Micale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2020.114004_b0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1017\/S0954579400003138","article-title":"The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave","volume":"12","author":"Marenco","year":"2000","journal-title":"Dev. Psychopathol."},{"key":"10.1016\/j.bcp.2020.114004_b0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/syn.20857","article-title":"Structural abnormalities revealed by magnetic resonance imaging in rats prenatally exposed to methylazoxymethanol acetate parallel cerebral pathology in schizophrenia","volume":"65","author":"Chin","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.bcp.2020.114004_b0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00441-013-1692-9","article-title":"Leading compounds for the validation of animal models of psychopathology","volume":"354","author":"Micale","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bcp.2020.114004_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-42532-z","article-title":"Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats","volume":"9","author":"Drazanova","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114004_b0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuropharm.2018.10.026","article-title":"Development of the MAM model of schizophrenia in mice: sex similarities and differences of hippocampal and prefrontal cortical function","volume":"144","author":"Chalkiadaki","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114004_b0030","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2009.01.031","article-title":"Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia","volume":"204","author":"Lodge","year":"2009","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bcp.2020.114004_b0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2174\/138161212799316217","article-title":"From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments","volume":"18","author":"Howes","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2020.114004_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1574889809666140307115532","article-title":"Therapeutic potential of cannabinoids in schizophrenia","volume":"9","author":"Kucerova","year":"2014","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.bcp.2020.114004_b0045","doi-asserted-by":"crossref","first-page":"5131","DOI":"10.2174\/138161212802884681","article-title":"A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation","volume":"18","author":"Waldo Zuardi","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bcp.2020.114004_b0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrd.2016.28","article-title":"Altering the course of schizophrenia: progress and perspectives","volume":"15","author":"Millan","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2020.114004_b0055","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.schres.2016.02.004","article-title":"Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia","volume":"172","author":"Peres","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bcp.2020.114004_b0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neuropharm.2018.11.035","article-title":"Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia","volume":"146","author":"Stark","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bcp.2020.114004_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neubiorev.2017.02.006","article-title":"Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: implications for novel schizophrenia treatments","volume":"75","author":"Renard","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2020.114004_b0070","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12640-017-9718-9","article-title":"Suppression of methamphetamine self-administration by ketamine pre-treatment is absent in the methylazoxymethanol (MAM) rat model of schizophrenia","volume":"32","author":"Ruda-Kucerova","year":"2017","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bcp.2020.114004_b0075","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/15622975.2016.1190032","article-title":"Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats","volume":"18","author":"Ruda-Kucerova","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0080","doi-asserted-by":"crossref","first-page":"12330","DOI":"10.1523\/JNEUROSCI.2808-11.2011","article-title":"Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia","volume":"31","author":"Valenti","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114004_b0085","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neubiorev.2014.03.014","article-title":"A systematic review and meta-analysis of the effects of antipsychotic medications on regional cerebral blood flow (rCBF) in schizophrenia: association with response to treatment","volume":"43","author":"Gooz\u00e9e","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2020.114004_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.brainresbull.2017.11.008","article-title":"Poly(I:C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment","volume":"137","author":"Drazanova","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bcp.2020.114004_b0095","doi-asserted-by":"crossref","first-page":"e920","DOI":"10.1038\/tp.2016.195","article-title":"Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose","volume":"6","author":"Seeman","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0100","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41401-018-0071-1","article-title":"Computational systems pharmacology analysis of cannabidiol: a combination of chemogenomics-knowledgebase network analysis and integrated in silico modeling and simulation","volume":"40","author":"Min Bian","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2020.114004_b0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/jcp.25914","article-title":"HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals","volume":"233","author":"Ve\u010de\u0159a","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bcp.2020.114004_b0110","article-title":"A preliminary study of endocannabinoid system regulation in psychosis: distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia","volume":"188","author":"D\u2019Addario","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bcp.2020.114004_b0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-7634(03)00005-8","article-title":"Trajectories of brain development: point of vulnerability or window of opportunity?","volume":"27","author":"Andersen","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2020.114004_b0120","unstructured":"G. Paxinos, C. Watson, A Stereotaxic Atlas of the Rat Brain, New York Acad., 1998."},{"key":"10.1016\/j.bcp.2020.114004_b0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2014.04.014","article-title":"The dual blocker of FAAH\/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis","volume":"87","author":"Navarria","year":"2014","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2020.114004_b0130","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000225979","article-title":"The hippocampus and nucleus accumbens as potential therapeutic targets for neurosurgical intervention in schizophrenia","volume":"87","author":"Mikell","year":"2009","journal-title":"Stereotact. Funct. Neurosurg."},{"key":"10.1016\/j.bcp.2020.114004_b0135","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.neubiorev.2012.07.012","article-title":"Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication","volume":"36","author":"Radua","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2020.114004_b0140","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.pharep.2019.04.020","article-title":"Olanzapine exposure diminishes perfusion and decreases volume of sensorimotor cortex in rats","volume":"71","author":"Drazanova","year":"2019","journal-title":"Pharmacol. Reports"},{"key":"10.1016\/j.bcp.2020.114004_b0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ilar.49.1.17","article-title":"Anesthesia and other considerations for in vivo imaging of small animals","volume":"49","author":"Hildebrandt","year":"2008","journal-title":"ILAR J."},{"key":"10.1016\/j.bcp.2020.114004_b0150","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/cercor\/bhl005","article-title":"Relationship between neural, vascular, and BOLD signals in isoflurane-anesthetized rat somatosensory cortex","volume":"17","author":"Masamoto","year":"2007","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.bcp.2020.114004_b0155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/mrm.21779","article-title":"Validation of cerebral blood perfusion imaging as a modality for quantitative pharmacological MRI in rats","volume":"61","author":"Bruns","year":"2009","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bcp.2020.114004_b0160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/mrm.25197","article-title":"Recommended implementation of arterial spin-labeled Perfusion mri for clinical applications: a consensus of the ISMRM Perfusion Study group and the European consortium for ASL in dementia","volume":"73","author":"Alsop","year":"2015","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.bcp.2020.114004_b0165","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jmri.1880080610","article-title":"In Vivo quantitative mapping of cardiac perfusion in rats using a noninvasive MR spin-labeling method","volume":"8","author":"Belle","year":"1998","journal-title":"J. Magn. Reson. Imag."},{"key":"10.1016\/j.bcp.2020.114004_b0170","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/jcbfm.2010.160","article-title":"Determination of the brain-blood partition coefficient for water in mice using MRI","volume":"30","author":"Leithner","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bcp.2020.114004_b0175","doi-asserted-by":"crossref","first-page":"e44316","DOI":"10.1371\/journal.pone.0044316","article-title":"Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation","volume":"7","author":"Platania","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2020.114004_b0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.bcp.2020.114004_b0185","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2016.06.007","article-title":"Current drug treatments targeting dopamine D3 receptor","volume":"165","author":"Leggio","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bcp.2020.114004_b0190","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.bcp.2013.08.010","article-title":"Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline","volume":"86","author":"Platania","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114004_b0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cellsig.2017.03.020","article-title":"The DRY motif and the four corners of the cubic ternary complex model","volume":"35","author":"Rovati","year":"2017","journal-title":"Cell Signal."},{"key":"10.1016\/j.bcp.2020.114004_b0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nchembio801","article-title":"Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor","volume":"2","author":"Yao","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2020.114004_b0205","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1021\/jm300482h","article-title":"Molecular determinants of selectivity and efficacy at the dopamine D3 receptor","volume":"55","author":"Newman","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114004_b0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature25758","article-title":"Structure of the D2 dopamine receptor bound to the atypical antipsychotic drug risperidone","volume":"555","author":"Wang","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114004_b0215","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression","volume":"17","author":"Grace","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2020.114004_b0220","article-title":"The role of dopamine D 3 receptors in the mechanism of action of cariprazine","author":"Calabrese","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bcp.2020.114004_b0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.bcp.2020.114004_b0230","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.112.193201","article-title":"Aberrant dopamine D2-Like receptor function in a rodent model of schizophrenia","volume":"343","author":"Perez","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2020.114004_b0235","doi-asserted-by":"crossref","first-page":"8942","DOI":"10.1073\/pnas.90.19.8942","article-title":"Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia","volume":"90","author":"Schmauss","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2020.114004_b0240","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/archpsyc.1997.01830240045007","article-title":"Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex: focal abnormalities in orbitofrontal cortex in schizophrenia","volume":"54","author":"Meador-Woodruff","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0245","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archpsyc.1997.01830150047009","article-title":"Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia: a postmortem study","volume":"54","author":"Gurevich","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0250","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/365441a0","article-title":"Dopamine D4 receptors elevated in schizophrenia","volume":"365","author":"Seeman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2020.114004_b0255","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1073\/pnas.98.2.625","article-title":"A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes","volume":"98","author":"Ilani","year":"2001","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bcp.2020.114004_b0260","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-2-3","article-title":"Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients","volume":"2","author":"Kwak","year":"2001","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bcp.2020.114004_b0265","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jneuroim.2005.11.018","article-title":"D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+-T cells","volume":"173","author":"Boneberg","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bcp.2020.114004_b0270","doi-asserted-by":"crossref","first-page":"26677","DOI":"10.3390\/ijms161125983","article-title":"The mRNA expression status of dopamine receptor D2, dopamine receptor D3 and DARPP-32 in T lymphocytes of patients with early psychosis","volume":"16","author":"Cui","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2020.114004_b0275","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000080958","article-title":"Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients","volume":"50","author":"Vogel","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.bcp.2020.114004_b0280","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1007\/s11033-010-0396-4","article-title":"Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?","volume":"38","author":"Urhan-Kucuk","year":"2011","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bcp.2020.114004_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101664","article-title":"microRNA dysregulation in neurodegenerative diseases: a systematic review","volume":"182","author":"Ju\u017awik","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bcp.2020.114004_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236055","article-title":"Interplay between MicroRNAs and oxidative stress in neurodegenerative diseases","volume":"20","author":"Konovalova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2020.114004_b0295","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neubiorev.2016.05.030","article-title":"Adolescence as a period of vulnerability and intervention in schizophrenia: insights from the MAM model","volume":"70","author":"Gomes","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bcp.2020.114004_b0300","article-title":"Prediction and prevention of the first psychotic episode: new directions and opportunities","volume":"241","author":"Marchese","year":"2014","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.bcp.2020.114004_b0305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00901","article-title":"Cannabidiol administered during peri-adolescence prevents behavioral abnormalities in an animal model of schizophrenia","volume":"9","author":"Peres","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114004_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8071058","article-title":"The potential of cannabidiol as a treatment for psychosis and addiction: Who benefits most? A systematic review","volume":"8","author":"Batalla","year":"2019","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2020.114004_b0315","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1021\/acs.jmedchem.9b00702","article-title":"The significance of chirality in drug design and synthesis of bitopic ligands as D3 receptor (D3R) selective agonists","volume":"62","author":"Battiti","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114004_b0320","doi-asserted-by":"crossref","first-page":"19059","DOI":"10.1038\/s41598-019-55723-5","article-title":"Discovery of Ganoderma lucidum triterpenoids as potential inhibitors against Dengue virus NS2B-NS3 protease","volume":"9","author":"Bharadwaj","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114004_b0325","doi-asserted-by":"crossref","first-page":"13587","DOI":"10.1038\/s41598-019-49984-3","article-title":"Fragment-based discovery of the first nonpeptidyl inhibitor of an S46 family peptidase","volume":"9","author":"Sakamoto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114004_b0330","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4155\/fmc-2018-0448","article-title":"Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents","volume":"11","author":"Pittal\u00e0","year":"2019","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.bcp.2020.114004_b0335","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2008.09.008","article-title":"Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors","volume":"597","author":"Tadori","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2020.114004_b0340","doi-asserted-by":"crossref","first-page":"12509","DOI":"10.1038\/s41598-018-30794-y","article-title":"Binding kinetics of cariprazine and aripiprazole at the dopamine D3 receptor","volume":"8","author":"Frank","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2020.114004_b0345","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-8993(99)01175-0","article-title":"Occlusion of the MCA by an intraluminal filament may cause disturbances in the hippocampal blood flow due to anomalies of circle of Willis and filament thickness","volume":"822","author":"Ozdemir","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.bcp.2020.114004_b0350","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/1074","article-title":"Neurogenic control of the cerebral microcirculation: is dopamine minding the store?","volume":"1","author":"Iadecola","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2020.114004_b0355","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/1099","article-title":"Dopaminergic regulation of cerebral cortical microcirculation","volume":"1","author":"Krimer","year":"1998","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2020.114004_b0360","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.neuroimage.2005.10.029","article-title":"Brain hemodynamic changes mediated by dopamine receptors: role of the cerebral microvasculature in dopamine-mediated neurovascular coupling","volume":"30","author":"Choi","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.bcp.2020.114004_b0365","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1073\/pnas.1211204110","article-title":"Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses","volume":"110","author":"Sylantyev","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2020.114004_b0370","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jnc.14101","article-title":"Epigenetic mechanisms underlying NMDA receptor hypofunction in the prefrontal cortex of juvenile animals in the MAM model for schizophrenia","volume":"143","author":"Gulchina","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bcp.2020.114004_b0375","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/npp.2016.172","article-title":"Altered glutamate and regional cerebral blood flow levels in schizophrenia: a 1H-MRS and pCASL study","volume":"42","author":"Wijtenburg","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bcp.2020.114004_b0380","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.schres.2010.03.036","article-title":"Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies","volume":"120","author":"Kempton","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bcp.2020.114004_b0385","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1176\/ajp.143.8.976","article-title":"Correlates of lateral ventricular size in chronic schizophrenia, I: behavioral and treatment response measures","volume":"143","author":"Losonczy","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0390","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.pnpbp.2008.09.020","article-title":"Effect of antipsychotic drugs on brain morphometry. A randomized controlled one-year follow-up study of haloperidol, risperidone and olanzapine","volume":"32","author":"Crespo-Facorro","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0395","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/schbul\/sbq040","article-title":"Risperidone administered during asymptomatic period of adolescence prevents the emergence of brain structural pathology and behavioral abnormalities in an animal model of schizophrenia","volume":"37","author":"Piontkewitz","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bcp.2020.114004_b0400","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.biopsych.2009.07.005","article-title":"Clozapine administration in adolescence prevents postpubertal emergence of brain structural pathology in an animal model of schizophrenia","volume":"66","author":"Piontkewitz","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bcp.2020.114004_b0405","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/can.2016.0034","article-title":"An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.bcp.2020.114004_b0410","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/01.pra.0000435036.83426.94","article-title":"Early intervention and the treatment of prodrome in schizophrenia: a review of recent developments","volume":"19","author":"Mokhtari","year":"2013","journal-title":"J. Psychiatr. Pract."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522030232X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629522030232X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:20:38Z","timestamp":1757769638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629522030232X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":82,"alternative-id":["S000629522030232X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114004","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2020.114004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114004"}}